Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A TWO WEEK DOUBLE-BLIND PLACEBO-CONTROLLED CROSSOVER STUDY TO COMPARE THE EFFICACY AND SAFETY OF A PREGABALIN/PF-00489791 COMBINATION VERSUS PREGABALIN ALONE IN PATIENTS WITH POST-HERPETIC NEURALGIA

NCT00599638 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00599638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00599638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A TWO WEEK DOUBLE-BLIND PLACEBO-CONTROLLED CROSSOVER STUDY TO COMPARE THE EFFICACY AND SAFETY OF A PREGABALIN/PF-00489791 COMBINATION VERSUS PREGABALIN ALONE IN PATIENTS WITH POST-HERPETIC NEURALGIA
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
April 9, 2008
Completion date
December 23, 2008
Enrollment
72 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

postherpetic neuralgia